Implications of quantitative susceptibility mapping at 7 Tesla MRI for microbleeds detection in cerebral small vessel

Valentina Perosa1, Johanna Rotta2, Renat Yakupov3,4

  • 1J. Philip Kistler Stroke Research Center, Massachusetts General Hospital, Boston, MA, United States.

Abstract

Insights

Quantitative susceptibility mapping (QSM) at submillimeter resolution significantly improves the detection of cerebral microbleeds (MBs) in elderly individuals. This advanced MRI technique reveals a higher prevalence of MBs in healthy older adults than previously understood.

Area of Science:

  • Neuroimaging
  • Radiology
  • Neurology

Background:

  • Cerebral microbleeds (MBs) are key indicators of cerebral small vessel disease (CSVD).
  • Standard MRI sequences like T2*-weighted imaging detect MBs, but Quantitative Susceptibility Mapping (QSM) offers enhanced identification and differentiation from calcifications.

Purpose of the Study:

  • To investigate the utility of submillimeter resolution QSM for detecting MBs in the context of CSVD.
  • To compare MB detection rates between QSM and traditional T2*-weighted imaging at different magnetic field strengths (3T and 7T).

Main Methods:

  • MRI scans (3T and 7T) were acquired from elderly participants, including healthy controls and patients with CSVD.
  • MBs were quantified using both T2*-weighted imaging and QSM.
  • Statistical analyses compared MB counts and classified subjects into CSVD subgroups or control groups based on imaging findings.

Main Results:

  • 7T QSM detected significantly more MBs compared to 3T T2*-weighted imaging (Mdn7T-QSM = 2.5 vs. Mdn3T-T2 = 0; p < 0.001).
  • A notable percentage of calcifications (6.1%) were identified as false positive MBs by QSM.
  • After accounting for false positives, 80.6% of healthy controls showed at least one MB, and the CSVD group exhibited a higher overall MB burden.

Conclusions:

  • Submillimeter resolution QSM enhances the detection of MBs in the elderly brain.
  • The study reveals a previously underestimated prevalence of MBs in the healthy elderly population.